The value of increased neopterin levels in reducing transfusion-transmitted virus infections: detection of a donation from a HBsAg positive chronic carrier by screening of neopterin in Turkish blood donors

References

• Fuchs D, Weiss G, Reibnegger G, Wachter H. The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases. Crit Rev Clin Lab Sci 1992; 29: 307–41
   PubMed Web of Science ®Google Scholar
• Murr C, Widner B, Wirleitner B, Fuchs D. Neopterin as a marker for immune system activation. Curr Drug Metab 2002; 3: 175–87
   PubMed Web of Science ®Google Scholar
• Honlinger M, Fuchs D, Hausen A, Reibnegger G, Schonitzer D, Werner ER, et al. Serum neopterin determination for the additional safeguarding of blood transfusions. Our experiences with 76,587 blood donors. Dtsch Med Wochenschr 1989; 114: 172–6
   PubMed Web of Science ®Google Scholar
• Schennach H, Murr C, Göchter E, Mayersbach P, Schönitzer D, Fuchs D. Factors influencing serum neopterin concentrations in a population of blood donors. Clin Chem 2002; 48: 643–5
   PubMed Web of Science ®Google Scholar
• Schennach H, Mayersbach P, Schonitzer D, Fuchs D. Additional neopterin screening to improve safety of blood donations. Pteridines 2000; 11: 76–80
   Google Scholar
• Fuchs D, Wachter H, Schonitzer D. Neopterin and blood transfusion. Dtsch Med Wochenschr 1992; 117: 1578–9
   PubMedGoogle Scholar
• Honlinger M, Fuchs D, Reibnegger G, Schonitzer D, Dierich MP, Wacher H. Neopterin screening and acute cytomegalovirus infections in blood donors. Clin Invest 1992; 70: 63
   PubMedGoogle Scholar
• Schennach H, Hessenberger G, Mayersbach P, Schonitzer D, Fuchs D. Acute cytomegalovirus infections in blood donors are indicated by increased serum neopterin concentrations. Med Microbiol Immunol (Berl) 2002; 191: 115–8
   PubMedGoogle Scholar
• Schennach H, Lanthaler AJ, Mayersbach P, Ulmer H, Muell K, Schoenitzer D, et al. Human parvovirus B19 detection in asymptomatic blood donors: association with increased neopterin concentrations. J Infect Dis 2002; 186: 1494–7
   PubMedGoogle Scholar
• Schennach H, Mayersbach P, Schönitzer D. Increased prevalence of IgM antibodies to Epstein-Barr virus and parvovirus B19 in blood donations with above-normal neopterin concentration. Clin Chem 1994; 40: 2104–5
   PubMedGoogle Scholar
• Schennach H, Schonitzer D, Fuchs D. Association between chronic hepatitis C virus infection and increased neopterin concentrations in blood donations (letter). Clin Chem 1998; 44: 2225–6
   PubMedGoogle Scholar
• Hoffmann G, Wirleitner B, Fuchs D. Potential role of immune system activation-associated production of neopterin derivatives in humans. Inflamm Res 2003; 52: 313–21
   PubMed Web of Science ®Google Scholar
• Werner ER, Bichler A, Dachsenbichler G, Fuchs D, Fuith LC, Hausen A, et al. Determination of neopterin in serum and urine. Clin Chem 1987; 33: 62–6
   PubMed Web of Science ®Google Scholar
• Westermann J, Thieman F, Gerstner L, Tatzber F, Kozak I, Bertsch T, Krüger C. Evaluation of a new simple and rapid enzyme-linked immunosorbent assay kit for neopterin determination. Clin Chem Lab Med 2000; 38: 345–53
   PubMed Web of Science ®Google Scholar
• Neopterin Brochure, IBL, www.idsltd.com/zipped/ibl/re59321.pdf.
   Google Scholar
• Gardner, MJ, Altman, DG, editors. Statistics with confidence: confidence intervals and statistical guidelines. London. Br Med J. 1989;40–1.
   Google Scholar
• Seifried E, Roth WK. Optimal blood donation screening annotation. Br J Haematol 2000; 109: 694–8
   PubMedGoogle Scholar
• Blejer JL, Carreras Vescio LA, Salamone HJ. Risk of transfusional-transmitted infections. Medicina (B Aires) 2002; 62: 259–78
   PubMedGoogle Scholar
• van der Poel CL, Seifried E, Schaasberg WP. Paying for blood donations: still a risk?. Vox Sang 2002; 83: 285–93
   PubMed Web of Science ®Google Scholar
• Vrielink H, Reesink HW. Transfusion-transmissible infections. Curr Opin Hematol 1998; 5: 396–405
   PubMedGoogle Scholar
• Roth WK, Buhr S, Drosten C, Seifried E. NAT and viral safety in blood transfusion. Vox Sang 2000; 78(Suppl 2)257–9
   PubMedGoogle Scholar
• Murr, C, Neurauter, G, Wirleitner, B, Fuchs, D. Neopterin to predict prognosis of infection and neoplasia. www.mtmi.vu.lt/eurogin-east/neopterin.htm.
   Google Scholar
• Wachter H, Fuchs D, Hausen A. Neopterin as marker for activated cell-mediated immunity: Immunological basis and clinical application. Adv Clin Chem 1989; 27: 81–141
   PubMed Web of Science ®Google Scholar
• Schreiber G, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. New Engl J Med 1996; 334: 1685–90
   PubMed Web of Science ®Google Scholar
• Busch MP, Korelitz JJ, Kleinman SH, Lee SR, Aubuchon JP, Schreiber GB. Declining value of alanine aminotransferase in screening of blood donors to prevent post-transfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study. Transfusion 1995; 35: 903
   PubMed Web of Science ®Google Scholar
• Roth WK, Weber M, Buhr S, Drosten C, Weichert W, Sireis W, et al. Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central Europe. Transfusion 2002; 42: 862–8
   PubMedGoogle Scholar
• Roth WK, Weber M, Petersen D, Drosten C, Buhr S, Sireis W, et al. NAT for HBV and anti-HBc testing increases blood safety. Transfusion 2002; 42: 869–75
   PubMedGoogle Scholar
• Aprili G, Gandini G, Piccoli P, Bressan F, De Gironcoli M, Mazzi R, et al. Detection of an early HIV-1 infection by HIV RNA testing in an Italian blood donor during the preseroconversion window period. Transfusion 2003; 43: 848–52
   PubMedGoogle Scholar
• Velati C, Romano L, Baruffi L, Pappalettera M, Carreri V, Zanetti AR. Residual risk of transfusion-transmitted HCV and HIV infections by antibody-screened blood in Italy. Transfusion 2002; 42: 989–93
   PubMedGoogle Scholar
• Reibnegger, G, Fuchs, D, Grubauer, G, Hausen, A, Wachter, H. Neopterin excretion during incubation period, clinical manisfestation and reconvalescence of viral infection, In: W Pfleiderer, Wachter, H, Curtius, HC, (eds). Biochemical and Clinical Aspects of Pteridines. Berlin-New York: Walter de Gruyter; 1984. p. 433–47.
   Google Scholar
• Zangerle R, Schonitzer D, Fuchs D, Most J, Dierich MP, Wachter H. Reducing HIV transmission by seronegative blood (letter). Lancet 1992; 339: 130–1
   PubMed Web of Science ®Google Scholar